Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Medivation, Inc.
Sponsor:
Collaborator:
Astellas Pharma Inc
Information provided by (Responsible Party):
Medivation, Inc.
ClinicalTrials.gov Identifier:
NCT02007512
First received: December 3, 2013
Last updated: March 5, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)